Fujian, China – 3 July 2026 — Avelon Healthcare Group is pleased to announce the signing of a strategic Memorandum of Understanding (MOU) to support the introduction and development of non-invasive glucose monitoring technology across Malaysia and Southeast Asia.
This collaboration marks an important step towards making diabetes management more comfortable, accessible, and patient-centred. By supporting the adoption of innovative non-invasive monitoring solutions, Avelon Healthcare aims to improve the daily experience of people living with diabetes and those who require regular blood glucose monitoring.
Beyond technology adoption, the collaboration will also focus on regulatory support, market access, professional training, and local after-sales service to ensure these innovations can be implemented responsibly and sustainably throughout the region.
At Avelon Healthcare, we believe that meaningful healthcare innovation is measured not only by technological advancement, but by the positive impact it has on patients' lives. This milestone reflects our ongoing commitment to bringing trusted global healthcare innovations closer to the communities we serve and empowering better health outcomes across Southeast Asia.
